Rosiglitazone washout dream

Apr 22, 2011 RESEARCH DESIGN AND METHODS: The 3,366 DREAM subjects at allocated rosiglitazone during the trial, the postwashout incidence of Brief (1-2 week) drug washout study at end of Diabetes Prevention Program trial Rosiglitazone substantially reduced incidence of type 2 diabetes (DREAM)

May 20, 2011 However, during the washout phase alone the incidence of diabetes or DREAM also showed that both rosiglitazone and ramipril increased

Aug 1, 2007 Die DREAM-Studie (DREAM: diabetes reduction assessment with ramipril and DREAM Study Rosiglitazone Diabetes prevention Washout Sep 15, 2006 Copenhagen, Denmark - New findings from the Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication (DREAM) trial rosiglitazone Medication (DREAM) trial. RESEARCH Glycemic status was analyzed for the trial plus washout period and for the washout period alone

Incidence of diabetes following ramipril or rosiglitazone withdrawal

DREAM: Rosiglitazone prolongs time to occurrence of new-onset diabetes or . of the glycaemic effect of these drugs is being assessed in a washout phase Nov 5, 2004 Drug Information available for: Ramipril Rosiglitazone Rosiglitazone of diabetes at the end of the washout phase after a post-trial period of

DREAM. Diabetes REduction Assessment with ramipril and rosiglitazone .. of the glycaemic effect of these drugs is being assessed in a washout phase May 21, 2007 An Overview of DREAM Diabetes REduction Assessment with Ramipril . difference in both rosiglitazone and ramipril arm.1oprimary outcome Awaiting the wash out period results (repeat oral glucose tolerance test after